# Iain B. McInnes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/iain-b-mcinnes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 104,988 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 142 |
| i10-index | 554 |
| OpenAlex ID | https://openalex.org/A5071482630 |
| ORCID iD | https://orcid.org/0000-0002-6462-4280 |
| Works | 1,293 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [Rheumatoid arthritis](https://scholariq.org/papers/rheumatoid-arthritis-2/)
- [Treating rheumatoid arthritis to target: recommendations of an international task force](https://scholariq.org/papers/treating-rheumatoid-arthritis-to-target-recommendations-of-an-international-task/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-3/)
- [\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.](https://scholariq.org/papers/neular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options](https://scholariq.org/papers/covid-19-and-the-cardiovascular-system-implications-for-risk-assessment/)
- [Immunopathogenesis of Rheumatoid Arthritis](https://scholariq.org/papers/immunopathogenesis-of-rheumatoid-arthritis/)
- [Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling](https://scholariq.org/papers/gain-of-function-mutations-in-ifih1-cause-a-spectrum-of-human-disease-phenotypes/)
- [Selective Expression and Functions of Interleukin 18 Receptor on T Helper (Th) Type 1 but not Th2 Cells](https://scholariq.org/papers/selective-expression-and-functions-of-interleukin-18-receptor-on-t-helper-th/)
- [Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial](https://scholariq.org/papers/abatacept-in-individuals-at-high-risk-of-rheumatoid-arthritis-apippra-a/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.